Replies to post #121690 on Biotech Values

[vinmantoo]

{{It's a game of tennis between science and nature. Science is prone to disruption (war, economics, etc.) where nature is perfect, never takes a day off, and it will capitalize on science's shortcomings. Even if one of those shortcomings is a scientific platform based on good intention.

So yes the possibility is real but that's not what I was refering to in my post concerning Atripla.}}


I beg to differ. It might be a theoretical possibility, but one that is so remote as to not be worth thinking about. HIV already has a high rate of mutation, so the possibility is already out there. But you have to consider that for HIV to be successful, it can't kill the host too quickly or its opportunity to be passed on will be dramatically reduced. Even if the drug increased the error rate so that a "super" virus could be made, it would have also have a better chance of losing the mutations that gave it super status.